News in Brief
Chaga Ltd becomes Scandinavia's largest medicinal mushroom producer
The CEO of Chaga Ltd, Siim Kabrits commented that the medicinal mushroom market is expected to grow at a rate of 9.85% between 2020 and 2027.
Data Bridge Market Research states that increasing awareness of medicinal mushrooms and ongoing R&D adds fuel to the demand for the release of medicinal mushrooms from various industries.
"Over the recent years there has been a significant rise towards the interest of medicinal mushrooms. As a result of this accession, the largest competence centre for medicinal mushroom production is established,” Kabrits said.
In cooperation with private forest owners, more than 600 chaga farms have been established in Estonia. Scandic Organic focuses on indoor medicinal mushroom production, such as Shitake, Lion’s Maine, Cordyceps and other well-known medicinal mushrooms.
“The new synergy between the two companies will provide us with the opportunity to expand the offer of indoor-grown mushrooms and gourmet mushrooms,” added Siim Raadik, the CEO of Scandic Organic.
The companies also plan to work together to develop a number of 'exciting' research and development projects.
Chaga Ltd, best known for its range of Chaga Health Immuno Elixirs, recently launched a new soft-pouch 25ml shot format of its elixir solution in a variety of flavours.
The brand's elixirs are based on a 100 year-old recipe, containing chaga, Nordic herbs, berry juices with vitamin C and honey, and they come in three different flavours - blackcurrant, sea buckthorn and rose-hip.
